DMD, dystrophin, 1756

N. diseases: 484; N. variants: 345
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Osteoporosis is a disease characterized by the deterioration of bone tissue and the consequent decrease in BMD and increase in bone fragility. 28265896 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Osteoporosis in all skeletal sites significantly related to increased risk of mortality in men and women, but the associations were stronger for BMD in the femur neck and total hip than in the lumbar spine. 30660675 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE BMD is a primary predictor of osteoporotic fracture and a key phenotype for the genetic study of osteoporosis. 15125790 2004
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE BMD is a heritable trait and risk indicator for osteoporosis. 19113921 2009
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE BMD (classified according to the WHO criteria for osteoporosis) of the hip and lumbar spine, the VFx (classified as a Genant score >1/>20% height loss), and radiological progression (modified stoke ankylosing spondylitis spinal score [mSASSS]) scores were obtained at baseline and at 4 years of TNFi treatment.Overall, 135 AS patients were included. 30690799 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE BMD measurements and kidney function for risk prediction were also evaluated; women were categorized by both reduced kidney function (stages 3-5) and osteoporosis status. 31754754 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE A major determinant of osteoporosis is peak BMD, which is a highly heritable trait. 16598376 2006
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE A number of studies investigated the distribution of BMD values and the prevalence of osteoporosis in China, but their findings varied. 31067339 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 AlteredExpression disease BEFREE A once-weekly pill containing risedronate and cholecalciferol had the equivalent antiresorptive efficacy on BMD compared with risedronate alone and improved 25(OH) D serum levels after 12 months of treatment without significant adverse events in Korean patients with osteoporosis. 31820121 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE A total 24 texture features demonstrated statistically significant differences between normal BMD and osteoporosis in the left sphenoid and a total of 31 texture features in the left condyle. 31153568 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Administrative health claims data were used to determine monthly rates of BMD testing and initiation of osteoporosis medicines in the 9-months post-intervention among targeted men and women compared to older cohorts of men and women. 28188561 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE Aiming to identify genomic loci associated with BMD variation at TRO and INT regions, we performed a GWAS utilizing the Framingham Heart Study (FHS, N = 6,912) as discovery sample and utilized the Women's Health Initiative (WHI) African-American subsample (N = 845), WHI Hispanic subsample (N = 446), and Omaha osteoporosis study (N = 971), for replication. 27311723 2016
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Altogether, 126 postmenopausal women belonging to four different groups were included: healthy (n=42), low BMD and no vertebral fractures (n=39), vertebral fractures and low BMD without a treatment (n=26), or receiving a treatment for osteoporosis (n=19). 31669252 2020
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Among subjects with spine fracture, 26 % met BMD criteria for osteoporosis. 28175980 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE And the rs12218 was found to be associated with plasma TG, HDL-C, LDL-C, and BMD levels in osteoporosis patients (P<0.05). 23522429 2013
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Any observational study, which tested the association between VDR BsmI genotypes and either BMD or osteoporosis at the femoral neck or spine in adult women, was included in the review. 15040830 2004
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. 15777680 2005
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE As he continued to run over the following 2 years, his mileage threshold to fracture steadily and rapidly decreased until he was diagnosed with severe osteoporosis (lumbar spine BMD Z-score of -3.2). 30972028 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Combination or sequential therapies of boneforming agents and anti-resorptive agents, or two kinds of anti-resorptive agents, or strontium ranelate and other anti-osteoporosis agents have the advantages on BMD compared with monotherapy. 28521691 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE Data from human diseases or dysfunctions identified 19 genes whose mutation was associated with human BMD: 9 genes each for human height and osteoporosis; 4 genes each for human osteoarthritis (OA) and fracture risk; and 2 genes each for adolescent idiopathic scoliosis (AIS), periodontitis, osteosarcoma growth, and tooth development. 31646011 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Despite normal areal BMD values assessed by dual-energy X-ray absorptiometry and no family history of osteoporosis, the patient demonstrated low lumbar spine trabecular bone score, as well as low peripheral trabecular volumetric BMD and deterioration of trabecular microarchitecture assessed by high-resolution peripheral quantitative computed tomography. 31273389 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE Disease severity (GOLD 3 and 4) was significantly associated with higher risk of vitamin D deficiency (p = 0.032), lower BMD (both men and women at all sites), higher frequency of osteoporosis (in women at all sites), lower skeletal mass index, and higher rate of low lean mass (in both men and women) than healthy controls and COPD patients with milder disease (GOLD 1 and 2). 29564475 2018
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE Faecal microbiota profiles were determined from 181 individuals with osteopenia (n = 61) or osteoporosis (n = 60), and an age- and gender-matched group with normal BMD (n = 60). 31378815 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 Biomarker disease BEFREE FN_BMD is an important risk factor for osteoporosis. 30172742 2018
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.100 GeneticVariation disease BEFREE However, specific genetic variants influencing BMD and contributing to the pathogenesis of osteoporosis are largely uncharacterized. 21773993 2011